SSTR2 positively associates with EGFR and predicts poor prognosis in nasopharyngeal carcinoma

Correlation of Somatostatin Receptor 2 Expression, 68Ga-DOTATATE PET Scan and Octreotide Treatment in Thymic Epithelial Tumors

(2022) Anja C. Roden et al.   Frontiers in Oncology

Correction to: Correlation of somatostatin receptor PET/CT imaging features and immunohistochemistry in neuroendocrine tumors of the lung: a retrospective observational study

(2022) Vittoria Rufini et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer

(2022) Shanu Modi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Somatostatin receptor 2 expression in nasopharyngeal cancer is induced by Epstein Barr virus infection: impact on prognosis, imaging and therapy

(2021) Matt Lechner et al.   Nature Communications

Diet-Derived Antioxidants and Their Role in Inflammation, Obesity and Gut Microbiota Modulation

(2021) Andrea Deledda et al.   Antioxidants

Simultaneously both expression of LMP-1 and methylation of E-cadherin: Molecular biomarker in stage IV of nasopharyngeal carcinoma patients

(2021) TD Lao et al.   Balkan Journal of Medical Genetics

Somatostatin receptor 2 is highly sensitive and specific for Epstein-Barr virus–associated nasopharyngeal carcinoma

(2021) Kartik Viswanathan et al.   HUMAN PATHOLOGY

SSTR2 in Nasopharyngeal Carcinoma: Relationship with Latent EBV Infection and Potential as a Therapeutic Target

(2021) Oscar Emanuel et al.   Cancers

Correlation of Somatostatin Receptor 1–5 Expression, [68Ga]Ga-DOTANOC, [18F]F-FDG PET/CT and Clinical Outcome in a Prospective Cohort of Pancreatic Neuroendocrine Neoplasms

(2021) Susanna Majala et al.   Cancers

Elevated HSP 90 associates with expression of HIF ‐1α and p‐ AKT and predicts the poor prognosis in the nasopharyngeal carcinoma

(2019) Juan Feng et al.   HISTOPATHOLOGY

Nasopharyngeal carcinoma

(2019) Yu-Pei Chen et al.   LANCET

Translational genomics of nasopharyngeal cancer

(2019) Chi Man Tsang et al.   SEMINARS IN CANCER BIOLOGY

Emerging functions of the EGFR in cancer

(2017) Sara Sigismund et al.   Molecular Oncology

SSTR2 promoter hypermethylation is associated with the risk and progression of laryngeal squamous cell carcinoma in males

(2016) Zhisen Shen et al.   Diagnostic Pathology

Cloning and Characterization of Novel Testis-Specific Diacylglycerol Kinase η Splice Variants 3 and 4

(2016) Eri Murakami et al.   PLoS One

The relation of EGFR expression by immunohistochemical staining and clinical response of combination treatment of nimotuzumab and chemotherapy in esophageal squamous cell carcinoma

(2015) J. Jia et al.   Clinical & Translational Oncology

Pathogenic role of Epstein–Barr virus latent membrane protein-1 in the development of nasopharyngeal carcinoma

(2013) Tomokazu Yoshizaki et al.   CANCER LETTERS

Somatostatin receptors: From signaling to clinical practice

(2013) Marily Theodoropoulou et al.   FRONTIERS IN NEUROENDOCRINOLOGY

Homogeneous EGFR amplification defines a subset of aggressive Barrett’s adenocarcinomas with poor prognosis

(2010) Andreas H Marx et al.   HISTOPATHOLOGY

Epstein-Barr Virus Latent Membrane Protein 1 Modulates Distinctive NF- B Pathways through C-Terminus-Activating Region 1 To Regulate Epidermal Growth Factor Receptor Expression

(2010) C.-P. Kung et al.   JOURNAL OF VIROLOGY

Identification of an Upstream Promoter of the Human Somatostatin Receptor, hSSTR2, Which Is Controlled by Epigenetic Modifications

(2008) Jérôme Torrisani et al.   ENDOCRINOLOGY